Abstract
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is an aggressive subtype. While trastuzumab plus pertuzumab significantly improves o
Funding Information
  • Aijian Endowment Fund (AJ005)

This publication has 28 references indexed in Scilit: